Dr. Michael Pollak, Director of the Stroll Cancer Prevention Centre at the JGH, has been chosen to serve as one of two leaders of a new Canada-wide team, aimed at translating fundamental research about breast cancer into effective treatment options for patients.
A ground-breaking new study has succeeded in compiling an “atlas” of genetic factors that are associated with estimated bone mineral density, one of the most clinically relevant factors in diagnosing osteoporosis.
An underdeveloped area in the brains of people with schizophrenia is the first clear anatomical signature for the disease, says a study by Dr. Hyman Schipper, a researcher at the Lady Davis Institute. This might lead to diagnosis of schizophrenia with an MRI scanner.
Coming in 2019: an online program for JGH patients with scleroderma, a rare autoimmune disease characterized by hardening of connective tissues. Included are instructional videos and advice on developing a personalized exercise routine and setting realistic goals.
Nervous about possible risks during overnight surgery? Don’t be. A study conducted at the JGH concluded that patients who undergo emergency surgery during overnight hours are at no greater risk of mortality than those who are operated upon during the day.
Dental research is playing an increasingly significant role in the Lady Davis Institute, especially in an exploration of pain in and around the joint on either side of the jaw bone—second only to back disorders as a source of chronic pain.
To enable advanced cancer patients to cope with difficulties at the end of life, JGH researchers hope to develop better psychological support through an intervention that helps individuals find meaning in their radically altered lives.
A pioneering research program is connecting artificial intelligence with the new field of radiomics to heighten the effectiveness of cancer treatment by gleaning as much information as possible from radiological imaging technology.